Summary of medicine characteristics - TIXYLIX INFANT COUGH SYRUP, TIXYLIX CHILDRENS COUGH SYRUP
1. NAME OF THE MEDICINAL PRODUCT
Tixylix Infant Cough Syrup
Tixylix Children’s Cough Syrup
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Active ingredient:
Glycerol 0.75ml per 5 ml
Excipient(s) with known effect:
Liquid maltitol (Lycasin) 2.16g/5ml dose.
Sodium benzoate (E 211) 10mg per 5ml dose.
Propylene glycol (E 1520) 34mg per 5ml dose.
Vanilla flavour (contains propylene glycol E1520)
Blackcurrant flavour (contains propylene glycol E1520)
For the full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Syrup
A clear viscous liquid
4.1
For the relief of dry tickly coughs
4.2
For oral administration.
Children 3 months to under 1 year:
One 5 ml spoonful three to four times a da
Children 1 to 5 years:
Two 5 ml spoonfuls three to four times a day
Allow 3 to 4 hours between doses.
Children under 3 months:
Not recommended
4.3 Contraindications
Hypersensitivity to any of the ingredients.
4.4 Special warnings and precautions for use
Not recommended for children under 3 months.
If symptoms persist for more than 3 days consult your doctor.
Important information about some of the ingredients:
This medicine contains:
Sodium benzoate (E211), 10mg per 5ml dose.
Maltitol may have a mild laxative effect. Calorific value 2.3Kcal/g. If you have been told by your doctor that your child is intolerant to some sugars, contact your doctor before taking this medicinal product.
Patients with rare hereditary problems of fructose intolerance should not take this medicine.
This medicine contains 34mg propylene glycol (E1520) in each 5ml dose.
Less than 1mmol sodium (23mg) per 5ml dose, that is to say essentially “sodium-free”.
4.5 Interaction with other medicinal products and other forms of interaction
No known drug interactions exist.
4.6 Fertility, Pregnancy and lactation
No data are available for glycerol on exposed pregnancies or use during lactation.
Caution should be exercised when prescribing during pregnancy.
4.7 Effects on ability to drive and use machines
On the basis of the known pharmacodynamic and adverse event profile for glycerol, this medicine has no major influence on the ability to drive and use machinery.
4.8 Undesirable effects
No adverse effects known.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
4.9 Overdose
4.9 OverdoseOverdosage with this product may possibly cause diarrhoea. Treatment should be symptomatic.
5.1
Pharmacodynamic properties
Glycerol has demulcent properties and may possibly block sensory cough receptors in the respiratory tract.
5.2 Pharmacokinetic properties
None stated.
5.3 Preclinical safety data
None stated.
6.1 List of excipients
Liquid maltitol (Lycasin)
Hydroxyethylcellulose
Sodium Benzoate (E211)
Citric Acid Monohydrate
Sodium Citrate
Vanilla flavour (contains propylene glycol E1520)
Blackcurrant flavour (contains propylene glycol E1520)
Purified Water
6.2 Incompatibilities
None stated.
6.3 Shelf life
36 months
6.4 Special precautions for storage
Keep the container tightly closed Do not store above 25°C
6.5 Nature and contents of container
Container: Amber-coloured glass bottle
Closure: Child resistant cap
Measuring spoon provided.
Pack size: 100ml, 150ml
Container: Amber-coloured polyethylene teraphthalate bottle
Closure: Child resistant cap
Measuring spoon provided.
Pack size: 150ml
6.6 Special precautions for disposal
6.6 Special precautions for disposalNot applicable.